Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer

NCT01157091 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Clear Cell Renal Cell Carcinoma
Recurrent Renal Cell Cancer
Stage IV Renal Cell Cancer

Interventions

DRUG: pazopanib hydrochloride
OTHER: laboratory biomarker analysis
OTHER: immunologic technique

Sponsor

City of Hope Medical Center